← Back to Patent Explorer
US5026537A Expired / Lapsed US ⏱️ 0.0 years remaining

Methods for imaging atherosclerotic plaque

Assignee: Janssen Biotech Inc
•
Filing: 1989-04-06
•
Granted: 1991-06-25
•
Expires: 2009-04-06
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract This invention pertains to a method of imaging atherosclerotic plaque using radiolabeled monoclonal antibodies that are specific for activated platelets or activated endothelial cells. The method is capable of determining the site of endothelial injury. This method involves the administration of a platelet-specific labeled monoclonal antibody or antibody fragment to a patient. The antibody is allowed to accumulate at the plaque site and the plaque is then scanned with a photoscanner. The detected signals are then converted into an image of the plaque.

Inventors

  • 👤 Peter E. Daddona
  • 👤 Harvey J. Berger
  • 👤 Rodger P. McEver

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-24 14:23
CPC Classifications
A; A61; A61K; A61K51/00; A61K51/02; A61K51/04; A61K51/08; A61K51/10; A61K51/1018; A61K2123/00; Y; Y10; Y10S; Y10S424/00; Y10S424/809; Y10S530/00; Y10S530/866

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 82 words
A method of imaging an atherosclerotic plaque, comprising the steps of: a. administering to an individual suspected of having an atherosclerotic plaque, an effective amount of a radiolabeled monoclonal antibody or fragment thereof, specific for activated platelet or endothelial cell membrane protein GMP-140; b. allowing the radiolabeled monoclonal antibody or antibody-fragment to accumulate at the plaque site; c. detecting the signal generated by the radiolabel by means of a photoscanning device; d. converting the detected signal into an image of the plaque.
Claim 2
Independent Claim 82 words
A method of imaging an atherosclerotic plaque, comprising the steps of: a. administering to an individual suspected of having an atherosclerotic plaque, an effective amount of a radiolabeled monoclonal antibody or fragment thereof, specific for activated platelet or endothelial cell membrane protein GMP-140; b. allowing the radiolabeled monoclonal antibody or antibody-fragment to accumulate at the plaque site; c. detecting the signal generated by the radiolabel by means of a photoscanning device; d. converting the detected signal into an image of the plaque.
Claim 3
Dependent Claim 26 words
A method of claim 1, wherein the monoclonal antibody fragment is selected from the group consisting of Fab, Fab', F(ab') 2 , and F v fragments.
Claim 4
Dependent Claim 24 words
A method of claim 1, wherein the monoclonal antibody is labeled with a radioactive material selected from the group consisting of Technetium-99m and Indium-111.
Claim 5
Dependent Claim 11 words
A method of claim 1, wherein the monoclonal antibody is S12.
Claim 6
Dependent Claim 13 words
A method of claim 1, wherein the atherosclerotic plaque is ulcerated or ruptured.
Claim 7
Independent Claim 67 words
A method of imaging an atherosclerotic plaque. comprising the steps of: administering to an individual suspected of having atherosclerotic plaque, an effective amount of a 99m Tc-labeled Fab fragment of monoclonal antibody S12; b. allowing the radiolabeled antibody fragment to accumulate at the plaque site; c. detecting the signal generated by means of a gamma camera; d. converting the detected signal into an image of the plaque.
Claim 8
Independent Claim 67 words
A method of imaging an atherosclerotic plaque. comprising the steps of: administering to an individual suspected of having atherosclerotic plaque, an effective amount of a 99m Tc-labeled Fab fragment of monoclonal antibody S12; b. allowing the radiolabeled antibody fragment to accumulate at the plaque site; c. detecting the signal generated by means of a gamma camera; d. converting the detected signal into an image of the plaque.

References Cited (Backward Citations)

US3875299A Cited
US4036945A Cited
US4359453A Cited
US4577636A Cited
US4610241A Cited
US4820505A Cited
US4877599A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1994-06-24 1994-12-24 1995-06-25 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1998-06-24 1998-12-24 1999-06-25 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2002-06-24 2002-12-24 2003-06-25 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag